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Abstract
Background Patients after successful repair of coarctation
of aorta (CoAo) are at risk of hypertension at rest and
associated end-organ damage. The aim of the study was to
assess arterial stiffness and function in adults after coarc-
tation repair in relation to descending aorta (AoD) residual
coarctation and patient’s age at operation.
Methods 85 patients after CoAo repair (53 males) aged
34.6 ± 10.3 years; median age at operation 0.9 ±
8.2 years. The control group—30 individuals (18 males)
at mean age 33.6 ± 8.2 years. The following central
parameters: augmentation pressure (AP) and augmentation
index (AI) as well as peripheral vascular parameters:
ﬂow-mediated dilatation (FMD), nitroglycerin-mediated
vasodilatation (NMD), intima-media thickness (IMT) and
pulse wave velocity (PWV) were measured.
Results 47 CoAo-repaired patients were normotensive,
and compared to control, they presented higher values of
central parameters AP (7.3 ± 4.6 vs. 4.4 ± 3.6 mmHg;
p = 0.002) and AI (18.6 ± 10.4 vs. 13.5 ± 4.3%;
p = 0.03); as well as the increased PWV (6.8 ± 1.2 vs.
5.4 ± 0.9 m/s; p = 0.003), while IMT was comparable
(0.53 ± 0.01 vs. 0.51 ± 0.01 mm; p = 0.06). The vaso-
dilatation was impaired in the normotensive patients: FMD
(4.8 ± 2.8 vs. 8.5 ± 2.3%; p = 0.00003) and NMD
(11.3 ± 4.6 vs. 19.8 ± 7.2%; p = 0.00001). The compar-
ison of recoarctation (46, 54%) to non-recoarctation (39,
46%) patients did not reveal any signiﬁcant differences
in resting systolic and diastolic pressures, as well as the
values of AI and the peripheral vascular parameters; the
value of AP was higher in the recoarctation patients
(10.5 ± 6.9 vs. 7.5 ± 4.1; p = 0.02) and correlated
positively with the gradient across AoD (r = 0.295,
p = 0.01). There was no signiﬁcant linear correlation
between age at the time of surgery and any of peripheral
arterial parameters.
Conclusions Residual stenosis in AoD does not affect the
arterial vasodilatation nor stiffness in patients after CoAo
repair. Early operation has no impact on peripheral vas-
cular remodeling or central pressure which supports the
claim that coarctation of the aorta is a systemic vascular
disorder which leads to progressive vascular and end-organ
damage despite early correction.
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Surgical correction of aortic coarctation (CoAo) has been
successfully performed for over half of the century. Life
expectancy remains to be reduced in patients with this con-
genital heart disease even after successful repair. The main
predictors of unfavorable prognosis in that group of patients
are arterial hypertension (AH) with subsequent end-organ
damage, and an inclination for development of early ath-
erosclerosis[1–8].Thepathophysiologyofhypertensionthat
occurs after coarctation repair is still a matter of debate.
Despite successful removal of residual stenosis in the
descending aorta (AoD), hypertension is still present in
30–50% of patients, which suggests that CoAo might not be
the simple mechanical obstruction of the main artery but
more likely a widespread anomaly of the cardiovascular
system [3, 4, 8, 10, 11]. At the same time most of the avail-
able data suggests that prognosis is strongly affected by the
age at the surgery; AH is less frequent in patients who have
undergone coarctation repair in infancy [5, 7, 8, 12–16].
Manyresearcherspointoutthatearlydetectionandtreatment
of stenosis of the AoD is associated with better outcomes,
since this condition plays a signiﬁcant role in the pathway
leading to AH [5, 17, 18]. Functional and histopathological
studies proved increased stiffness of the precoarctation part
of the aorta [19, 20]. According to the majority of publica-
tions, this phenomenon forms the basis for complex inter-
actions present in CoAo—functional abnormalities in
vascular reactivity and baroreceptor-reﬂex function, as well
as irreversible arterial remodeling—all leading to hyper-
tension in the studied population [3, 5, 21]. Elucidation of
potential mechanisms underlying vascular remodeling, rep-
resenting increased vascular stiffness and altered reactivity
in CoAo, brings us closer in understanding the pathophysi-
ology of hypertension in those patients. It is justiﬁed, in our
opinion, to carry out the analysis of signiﬁcance of residual
gradient across AoD for vascular remodeling and the inﬂu-
ence exerted by the age at intervention.
The aim of the study was to evaluate arterial stiffness and
function in adult patients after coarctation repair, in relation
to residual gradient across AoD as well as age at the
operation.
Materials and methods
The study population consisted of 85 coarctation-repaired
patients (53 males) aged 19–64 years (mean 34.6 ±
10.3 years) who had undergone operation at the age of
0.5–34 years (10.9 ± 8.2 years), cared by our adult congen-
italheartdiseaseoutpatientclinic.Thecontrolgroupconsisted
of 30 healthy individuals (18 males) aged 24–48
(33.6 ± 8.2 years). Most patients in the study group—74
(87%)hadundergoneDacronpatchrepairbythesamecardiac
surgeon;4 (5%)had undergone subclavianﬂap aortoplasty, 7
(8%)—end-to-end anastomosis. Two patients received aortic
prosthetic valve (St. Jude Medical). Nine patients had
undergone reoperation due to restenosis of the AoD, two
patientshadreceivednon-invasivetreatmentofrecoarctation,
another one had undergone stent-graft implantation into
the AoD due to aneurysm. The following congenital heart
diseases were additionally diagnosed: bicuspid aortic valve
without functional abnormality (n = 25, 29.4%), surgically
repaired ventrivular septal defect (n = 6, 7.1%), occluded
persistent arterial duct (n = 5, 5.9%), and trivial mitral
insufﬁciency (n = 21, 24.7%).
In order to avoid confounding factors which might inﬂu-
ence the vascular parameters, the following exclusion
criteria were established: acute and chronic inﬂammatory
diseases (in the preceding 3 months), underlying malig-
nancies, cigarette smoking within 12 h before the examina-
tion, diabetes mellitus. The investigators performing the
assessment of the peripheral and central vessel parameters
were blinded to results of the echocardiographic
examination.
Clinical characteristics of the study population, includ-
ing separately demographic and biochemical data for
normotensive patients, are presented in Table 1.
A cuff sphygmomanometer was used to measure blood
pressure at rest in all participants. Arterial hypertension
was recognised if the values of blood pressure exceeded
140/90 mmHg, or a report of a prior diagnosis of hyper-
tension and current antihypertensive treatment, in accor-
dance with the guidelines established in 2007 by the
European Society of Hypertension and the European
Society of Cardiology [15]. The study involved both
patients on antihypertensive therapy and patients from
whom antihypertensive therapy was withdrawn for at least
48 h before the study [22].
Echocardiographic examination was performed using
Vivid 7 (GE Healthcare) with 2.5 MHz probe in 2D, M and
Doppler modes. The single investigator evaluated cardiac
anatomy and left ventricular systemic function (Simpson
biplane method), normal systolic function was a criterion
for inclusion in the study. The severity of residual stenosis
of the AoD was determined by evaluation of the supra-
sternal notch. Restenosis was diagnosed when the AoD
pressure gradient was equal to or greater than 20 mmHg
and rest arm-leg systolic blood pressure gradient exceeded
20 mmHg. Based on those measurements, the study pop-
ulation was divided into subgroups with residual aortic
stenosis [AoD(?)] and without it [AoD(-)] [17].
A clinical characteristics of patients with recoarctation
as well as patients without residual stenosis in the AoD
(both demographic and biochemical data) is presented in
Table 3.
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123Flow mediated dilatation
The examination was performed between 8 and 10 a.m. in a
temperature-controlled room (20–22C) with subjects rest-
ing in a supine position. Conduit-vessel endothelial function
was assessed using the ultrasound measurement of brachial
artery diameter (Bad) during changes in brachial artery ﬂow
(7–12 MHz linear array transducer, Logic 7, GE). A 5-cm
length of the brachial artery was imaged in a longitudinal
sectionabovetheantecubitalfossaandwiththeoptimalprobe
site marked on the skin. Baseline images of Bad and Doppler
velocities from the center of the vessel were recorded. A
distal-occluding forearm cuff placed just below the antecu-
bital fossa was inﬂated to 50 mmHg above the systolic pres-
sure for 5 min. A brachial artery scan was then obtained for
120 s after the cuff deﬂation, including a repeated ﬂow
velocityrecordingfortheﬁrst15 safterthecuffrelease.After
10 min of rest, sublingual nitroglycerin (0.5 mg) was
administrated to determine the maximum obtainable exoge-
nous vasodilatatory response. Bad and blood ﬂow were
measuredfollowingNTG.Theresponseofthevesseldiameter
to reactive hyperemia [ﬂow-mediated dilatation (FMD)] was
calculated and expressed as the percentage change relative to
the diameter measured immediately before the cuff inﬂation.
T h ed i a m e t e rc h a n g ec a u s e db yn i t r o g l y c e r i nw a se x p r e s s e d
as the percentage change relative to the recovery scan
[nitroglycerin-mediated dilatation (NMD)] [12].
IMT B-mode carotid ultrasound
Carotid scans were performed using a Logic 7, GE
ultrasound machine with the 7–12 MHz transducer.
Following the acquisition of the scan, the diastolic
images with the best demonstrated intimal medial
thickening (IMT) were analysed. Both near and far walls
of the common carotid artery were visualised on the
same scan to ensure the transducer was transecting the
artery at 90. Scans were read by a single observer
blinded to the other results. Images were analysed using
a quantitative analysis package (Siemens) giving an axial
resolution of 0.001 mm. Measurements of IMT were
made at 1 mm intervals over a 10 mm segments of the
vessel. The maximal and mean IMT measurements were
determined for the near and far walls of the left and
right common carotid arteries [1].
Pulse wave velocity
For the assessment of the pulse wave velocity (PWV), the
pulse wave was obtained over the right radial artery and at
the neck for the right common carotid artery. Transit time
was measured as the time between the foot of the pulse
wave and the R wave in concurrently recorded ECG. The
data were collected directly into the laptop (HP Pavillion
Entertainment PC). Pulse transit time was determined as
the average of consecutive beats during the last 10 s. Time
delay (t) was calculated as the difference between those
two transit times. The distance (d) travelled by the pulse
wave was measured over the body surface at the distance
between the two locations. Pulse wave velocity was cal-
culated as PWV = d/t m/s by the SphygmoCor device
(SphygmoCor PVx, Version 8.0, AtCor, Sydney, Australia)
[23].
Table 1 Baseline characteristics of the study population and the control group
CoAo
(N = 85)
CoAo AH(-)
(N = 47)
Controls
(N = 30)
p CoAo
versus controls
pCoAo AH(-)
versus controls
Male:female 53:32 30:17 18:12 0.99 0.81
Age (years), mean ± SD
(median; range)
34.6 ± 10.3 (33; 18–64) 33.7 ± 8.2 (33; 18–60) 33.6 ± 8.2 (32; 18–61) 0.8 0.92
Age at surgery (years) 10.9 ± 8.2 10.8 ± 7.6 – – –
Smokers (current) 6 (7%) 4 (8%) 2 (6.5%) 0.61 0.46
BMI (kg/m
2) 25.3 ± 3.3 25.4 ± 3.3 24.5 ± 3.1 0.09 0.08
Height (cm) 171.4 ± 9.2 169.6 ± 9.7 173.8 ± 9.6 0.49 0.46
Weight (kg) 74.6 ± 11.8 73.2 ± 12.5 71.8 ± 13.8 0.67 0.57
Bicuspid aortic valve 25 (29%) 13 (28%) – – –
Glucose (mmol/l) 5.2 ± 0.8 5.2 ± 0.7 5.2 ± 0.2 0.1 0.14
Creatinine (umol/l) 74.8 ± 12.8 72.9 ± 11.2 75.4 ± 8.9 0.32 0.41
Total cholesterol (mmol/l) 5.3 ± 1.0 5.2 ± 0.8 5.4 ± 0.9 0.9 0.85
LDL-cholesterol (mmol/l) 3.0 ± 0.6 2.9 ± 0.7 3.0 ± 0.4 0.8 0.99
HDL-cholesterol (mmol/l) 1.4 ± 0.3 1.4 ± 0.3 1.3 ± 0.2 0.79 0.84
Triglycerides (mmol/l) 1.4 ± 0.4 1.3 ± 0.5 1.3 ± 0.6 0.8 0.67
BMI body mass index
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Central parameters of the aortic pulse wave and arterial
wall stiffness of the large conduit arteries were measured
using pulse wave analysis performed with applanation
tonometry (SphygmoCor PVx, Version 8.0, AtCor, Sydney,
Australia). Brachial blood pressure (BP) needed for the
algorithm of the procedure was measured non-invasively
after 15 min of rest in the supine position with Omron
705IT device (Omron Healthcare, Kyoto, Japan). For the
assessment of the parameters of the central aortic pulse
wave, the pulse waveform of the radial artery was recorded
for 10 s. and a radial to aortic transfer function was used to
derive the central aortic pulse pressure (APP) waveform
from which the aortic systolic pressure (ASP), aortic dia-
stolic pressure (ADP), augmentation pressure (AP) and
augmentation index (AI) were determined. The central
aortic pulse wave peaks twice. The ﬁrst peak is caused by
ejection of blood from the left ventricle and the second is a
result of the wave reﬂected from the periphery, overlapping
the primary one. The AP is the difference between the
second and the ﬁrst peak, and the AI is the ratio of AP to
APP expressed as a percentage [22].
Statistics
Data are presented as the mean value with standard devi-
ation (±SD). For variables following normal distribution,
statistical analysis was performed with the Student t test
for unpaired samples. For variables not following normal
distribution, the Mann–Whitney U test was used. To
determine the relationship between variables, the Spearmen
rank-orderorPearsoncorrelationwereanalysed.Categorical
variableswerecomparedusingthechi-squaretest.Resultsof
p\0.05 were considered statistically signiﬁcant.
Informed consent was obtained from each patient, and
our study protocol, as approved a priori by our institution’s
human research committee, conformed to the ethical
guidelines set forth by the 1975 Declaration of Helsinki.
Results
As shown in Table 2, postcoarctectomy patients had sig-
niﬁcantly elevated values of both peripheral systolic and
diastolic resting blood pressure (SBP and DBP), as com-
pared to the control group (140.3 ± 16.7 vs.
125.6 ± 7.0 mmHg; p = 0.00001 and 75.2 ± 9.6 vs.
69.9 ± 9.8 mmHg; p = 0.002). Values of ASP were also
signiﬁcantly increased (114.9 ± 13.5 vs. 102.4 ± 10.3
mmHg; p = 0.0003) but ADP did not differ between the
groups (70.7 ± 9.2 vs. 70.2 ± 9.1; p = 0.7). Central
parameters: APP in the studied group was higher than in
the control patients (43.2 ± 11.9 vs. 32.1 ± 9.8 mmHg;
p = 0.0003), similar results were obtained for AP (9.2 ±
6.0 vs. 4.4 ± 3.6 mmHg; p = 0.00002) and AI (20.3 ±
9.6 vs. 13.5 ± 4.3%; p = 0.003). Postcoarctectomy sub-
jects had substantially increased arterial stiffness, as shown
by higher values of PWV (7.7 ± 1.7 vs. 5.4 ± 0.9 m/s;
p = 0.003) and IMT (0.63 ± 0.2 vs. 0.51 ± 0.1 mm;
p = 0.008). Flow-mediated dilatation after hyperemia, as
well as endothelium independent vasodilatation (NMD)
were signiﬁcantly impaired in patients, when compared
Table 2 Vascular characteristics of the entire study population, normotonic coarctation repair patients and comparison to the control group
CoAo
(N = 85)
CoAo AH(-)
(N = 47)
Controls
(N = 30)
p CoAo versus
controls
p CoAo AH(-)
versus controls
HR (beats/min) 70.6 ± 11.8 70.5 ± 9.2 69.4 ± 10.4 0.2 0.2
SBP at rest (mmHg) 140.3 ± 16.7 125.5 ± 9.2 120.6 ± 7.0 0.00001 0.45
DBP at rest (mmHg) 75.2 ± 9.6 73.3 ± 9.9 69.9 ± 9.8 0.002 0.35
ASP (mmHg) 114.9 ± 13.5 110.8 ± 10.8 102.4 ± 10.3 0.0003 0.0005
ADP (mmHg) 70.7 ± 9.2 70.5 ± 8.7 70.2 ± 9.1 0.7 0.95
APP (mmHg) 43.2 ± 11.9 39.6 ± 8.8 32.1 ± 9.8 0.00001 0.0001
AP (mmHg) 9.2 ± 6.0 7.3 ± 4.6 4.4 ± 3.6 0.00002 0.002
AI (%) 20.3 ± 9.6 18.6 ± 10.4 13.5 ± 4.3 0.0002 0.03
PWV (m/s) 7.7 ± 1.7 6.8 ± 1.2 5.4 ± 0.9 0.0003 0.03
IMT (mm) 0.63 ± 0.2 0.51 ± 0.1 0.51 ± 0.1 0.008 0.06
FMD (%) 4.9 ± 3.4 4.8 ± 2.8 8.5 ± 2.3 0.00005 0.00003
NTG (%) 10.6 ± 5.2 11.3 ± 4.6 19.8 ± 7.2 0.00001 0.00001
CoAo patients after coarctation repair, CoAo AH(-) normotonic coarctation repaired patients, HR heart rate, SBP systolic blood pressure, DBP
diastolic blood pressure, ASP central systolic pressure, ADP central diastolic pressure, APP central pulse pressure, AP augmentation pressure, AI
augmentation index, PWV pulse wave velocity, IMT intima-media thickness, FMD ﬂow-mediated dilatation, NMD nitroglycerin-mediated
vasodilatation
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123with the controls (4.9 ± 3.4 vs. 8.5 ± 2.3%; p = 0.00005
and 10.6 ± 5.2 vs. 19.8 ± 7.2%; p = 0.00001).
Forty-seven patients after CoAo repair had normal blood
pressure [CoAo AH(-)]. Comparison with the controls
revealeddifferencesincentralparameters—APP(39.6 ± 8.8
vs. 32.1 ± 9.8 mmHg; p = 0.0001), AP (7.3 ± 4.6 vs.
4.4 ± 3.6 mmHg; p = 0.002) and AI (18.6 ± 10.4 vs.
13.5 ± 4.3%; p = 0.03) in the studied normotensives were
signiﬁcantly higher than among controls. Peripheral vessel
parameter analysis showed that PWV of CoAo AH(-)
patients was higher than in the control group (6.8 ± 1.2 vs.
5.4 ± 0.9 m/s; p = 0.003), but IMT was comparable
(0.53 ± 0.1 vs. 0.51 ± 0.1 mm; p = 0.06). The studied
grouprevealedlesserdegreeofvasodilatationasexpressedin
valuesofFMD(4.8 ± 2.8vs.8.5 ± 2.3%;p = 0.00003)and
NMD (11.3 ± 4.6 vs 19.8 ± 7.2%; p = 0.00001).
Residual stenosis of the AoD was found in 46 patients
[AoD(?)], their pressure gradient ranged from 20.0 to
70.0 mmHg (mean 35.3 ± 11.9 mmHg), and systolic arm
to leg gradient from 20 to 61 mmHg (mean 36.7 ±
13.9 mmHg). In the remaining 39 patients [AoD(-)], the
pressure gradient ranged from 4.0 to 19.0 mmHg (mean
16.2 ± 6.1 mmHg) and systolic arm to leg gradient respec-
tively, -4 to 17 mmHg (4.8 ± 8.6 mmHg). Demographic
characteristics of analysed groups of patients are presented in
Table 3.AoD(?)patientswerematchedforage(35.5 ± 10.4
vs.33.8 ± 10.4 years;p = 0.54)andnumberofsmokers(8.6
vs.5.1%;p = 0.69).Therewasalsonodifferencebetweenthe
groupsinBMI(25.0 ± 3.0vs.26.6 ± 3.6 kg/m
2;p = 0.08),
weight (75.5 ± 11.5 vs. 73.2 ± 12.5 kg; p = 0.67), height
(173.5 ± 8.6 vs. 170.8 ± 9.5 cm; p = 0.48), neither in the
biochemical parameters. The only parameter differing
between the groups was the age at the time of surgical
procedure—AoD(-) patients were operated on earlier than
AoD(?)patients(12.4 ± 7.9vs.9.4 ± 8.0 years;p = 0.04).
As shown in Table 4, resting SBP and DBP did not differ
between the subgroups with and without residual gradient in
the AoD (143.3 ± 14.7 vs. 136.6 ± 14.9 mmHg; p = 0.06
and 81.2 ± 9.3 vs. 79.1 ± 10.1 mmHg; p = 0.99), as well
asthe numberofpatients with hypertension (40.5vs.47.9%,
p = 0.64). Central parameters: comparing patient groups
AoD(?) and AoD(-) showed that ASP was higher in
Table 3 Baseline
characteristics and comparison
of patients with respect to the
presence of recoarctation
AoD(?)
(N = 46)
AoD(-)
(N = 39)
p AoD(?) versus
AoD(-)
Male:female 20:16 33:16 0.24
Age (years) 33.5 ± 10.4 35.8 ± 10.4 0.54
Age at surgery (years) 12.4 ± 7.9 9.4 ± 8.0 0.04
Smoker (current) 4 (8.6%) 2 (5.1%) 0.64
BMI (kg/m
2) 25.0 ± 3.0 25.6 ± 3.6 0.08
Height (cm) 173.5 ± 8.6 170.8 ± 9.5 0.48
Weight (kg) 75.5 ± 11.5 73.2 ± 12.5 0.67
Glucose (mmol/l) 5.3 ± 0.6 5.2 ± 0.6 0.13
Creatinine (umol/l) 76.9 ± 13.1 72.2 ± 12.2 0.32
Total cholesterol (mmol/l) 5.2 ± 0.9 5.4 ± 0.7 0.91
LDL-cholesterol (mmol/l) 2.9 ± 0.8 3.0 ± 0.7 0.78
HDL-cholesterol(mmol/l) 1.3 ± 0.2 1.4 ± 0.4 0.83
Triglycerides (mmol/l) 1.3 ± 0.5 1.5 ± 0.9 0.79
Table 4 Vascular characteristics and comparison of patients with
respect to the presence of recoarctation
AoD(?)
(N = 46)
AoD(-)
(N = 39)
p AoD(?)
versus AoD(-)
HR (beats/min) 69.8 ± 13.4 71.6 ± 6.7 0.47
SBP (mmHg) 143.3 ± 14.7 136.6 ± 14.9 0.06
DBP (mmHg) 81.2 ± 9.3 79.1 ± 10.1 0.99
Hypertonics (%) 4 (8.6%) 2 (5.1%) 0.69
ASP (mmHg) 116.3 ± 14.2 110.0 ± 12.0 0.05
ADP (mmHg) 72.6 ± 9.9 69.3 ± 9.9 0.09
APP (mmHg) 46.7 ± 13.8 38.3 ± 6.9 0.001
AP (mmHg) 10.5 ± 6.9 7.5 ± 4.1 0.02
AI (%) 21.0 ± 8,5 19.3 ± 8.5 0.44
PWV (m/s) 7.6 ± 1.3 7.8 ± 2.0 0.49
IMT (mm) 0.67 ± 0.2 0.64 ± 0.1 0.45
FMD (%) 4.6 ± 3.2 5.1 ± 3.9 0.06
NTG (%) 10.5 ± 5.2 10.8 ± 5.0 0.75
CoAo patients after coarctation repair, CoAo AH(-) normotonic
coarctation repaired patients, HR heart rate, SBP systolic blood
pressure, DBP diastolic blood pressure, ASP central systolic pressure,
ADP central diastolic pressure, APP central pulse pressure, AP aug-
mentation pressure, AI augmentation index, PWV pulse wave veloc-
ity, IMT intima-media thickness, FMD ﬂow-mediated dilatation,
NMD nitroglycerin-mediated vasodilatation
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123patients with recoarctation but this elevation did not reach
statistical signiﬁcance (116.3 ± 14.2 vs. 111.0 ± 12.0
mmHg; p = 0.05), while ADP did not differ between the
groups (72.6 ± 9.9 vs. 69.3 ± 9.9 mmHg; p = 0.09). APP
as well as AP were higher in patients with recoarctation
(46.7 ± 13.8 vs. 38.3 ± 6.9; p = 0.001 and 10.5 ± 6.9 vs.
7.5 ± 4.1; p = 0.02). Such difference was not observed
comparing AI (21.0 ± 8.8 vs. 19.3 ± 8.5%; p = 0.44).
Variables concerning arterial stiffness PWV and IMT
(7.6 ± 1.3 vs. 7.8 ± 2.0 m/s; p = 0.49 and 0.67 ± 0.2 vs.
0.64 ± 0.1 mm; p = 0.45) were compared between both
subgroups. There were no differences in endothelium
dependent-vasodilatation (FMD), as well as endothelium
independent vasodilatation (NMD) (4.5 ± 3.2 vs. 5.2 ±
3.4%;p = 0.06and10.5 ± 5.2vs.10.8 ± 5.0%;p = 0.75).
Linear correlation analysis of results for the entire study
group concerning current age, age at the operation, gradient
across the AoD and analysed vascular parameters showed
signiﬁcant positive correlation between current age and
APP (r = 0.361; p = 0,001), AP (r = 0.444; p =
0.00002), as well as AI (r = 0.481; p = 0.00001). Gradi-
ent across the AoD correlated positively with AP
(r = 0.295; p = 0.01). There was no signiﬁcant linear
correlation between age at the time of surgery and any of
peripheral arterial parameters (Table 5).
Discussion
Long-term follow-up shows that despite successful repair,
post-CoAo subjects are at high risk of AH and subsequent
end-organ complications [7, 12, 24, 25]. An important
pathogenetic link between these phenomena are changes in
arterial morphology and reactivity [2, 3, 12, 19, 22, 24,
26–c32]. It still remains to be unresolved, whether vascular
remodeling is an inherent part of this congenital condition
or results from increased blood pressure values [10, 21, 33].
Gidding et al. [34] were ﬁrst to show enhanced vasocon-
striction of the forearm arteries of CoAo patients, with no
such response in the vessels of the lower part of the body,
and that conﬁrmed functional and morphological autonomy
of the precoarctation arterial tree. Our study conﬁrms
presence of advanced vascular pathology in this group of
patients. To eliminate the inﬂuence of hypertension as a
causative factor, the analysis was limited to data obtained
from normotensive subjects. As described by the majority
of authors [2, 12, 22, 24, 26–28, 30], in this population of
patients reduced responses are present of both, endothelium
dependent arterial relaxation (FMD) in the brachial artery
and nitroglycerine-mediated vasodilatation (NMD) reﬂect-
ing depleted diastolic capability due to reduced capacity for
relaxation of vascular smooth muscle cells or structural
changes in the arterial wall. Increased stiffness of preco-
arctation arteries in postcoarctectomy patients is conﬁrmed
by higher values of PWV found in our study, a parameter
which is considered to be a robust index of arterial stiffness.
Similar conclusions were drawn by both de Divitiis et al.
[12] and Ou et al. [9]. On the other hand, our study found no
differences in intima-media thickness (IMT), which corre-
sponds to results of Swan et al. [1], but was not conﬁrmed
by others [17, 24]. What is more, Meyer et al. [2] reported
signiﬁcantly higher IMT in children, which may validate
congenital character of vascular changes in CoAo. It is
important, that the pathological values of peripheral vas-
cular parameters in the study are established risk factors for
serious cardiovascular events (stroke, coronary artery dis-
ease, general cardiac mortality) [35, 36]. Similar prognostic
value was determined for both AP and AI—indicators of
increased ASP, reﬂecting total vascular stiffness [37]. Our
study point towards a signiﬁcant increase in those param-
eters in patients after CoAo repair, which was also previ-
ously reported by Chen et al. [22]. Swan et al. [1] reported
that only values of central arterial pulse pressure (APP)
were higher than in the healthy population. Those authors
underline the usefulness of central vascular parameters—
facilitating early evaluation of the risk of potential suben-
docardial ischemia in the left ventricle, resulting from early
returned arterial wave, following increased stiffness of
precoarctation arterial tree [1, 21]. Our analysis conﬁrms
the thesis that vascular remodeling in patients after CoAo
repair is a phenomenon independent of AH [3, 10, 21, 22,
26]. The majority of scientists in that ﬁeld claim that
intrinsic abnormalities of the aortic wall and functional
abnormalities in vascular reactivity may lead to hyperten-
sion and simultaneously positive feedback can be provided
by hypertension itself by enhancing this remodeling [3, 10,
14, 22].
Table 5 Correlations between arterial parameters and current age,
age at the operation and gradient across the descending aorta
Current age Age at operation AoD gradient
APP p = 0.001 NS NS
r = 0.3605
AP p = 0.00007 NS p = 0.01
r = 0.4443 r = 0.259
AI p = 0.00007 NS NS
r = 0.617
FMD NS NS NS
NMD NS NS NS
IMT NS NS NS
PWV NS NS NS
APP aortic pulse pressure, AP augmentation pressure, AI augmenta-
tion index, PWV pulse wave velocity, IMT intima-media thickness,
FMD ﬂow-mediated dilatation, NMD nitroglycerin-mediated
vasodilatation
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the AoD. Although some researchers report that recoarc-
tation inﬂuences value of blood pressure [17, 38], still most
authors ﬁnd no association between AH and discreet
residual aortic narrowing [3, 8, 11, 12], which stands in line
with the results achieved in our analysis. We have found no
association between AH and discreet residual aortic nar-
rowing. The results of our study revealed no signiﬁcant
differences in stiffness and reactivity parameters between
patients with and without recoarctation. Moreover, there
have been no relevant correlations between those parame-
ters and transaortic gradient. Meyer et al. [2] also reported
no link between peripheral arterial reactivity and the level
of recoarctation in children operated for CoAo. On the
other hand, our patients with residual AoD gradient showed
higher values of augmentation and central pulse pressure.
The results of those parameters point to increased aortic
wall stiffness as well as abnormal wave transmission. In
healthy individuals with normal aorta, reﬂected wave
comes only from distal vasculature, while after CoAo
repair pressure waves are reﬂected not only from the distal
part of the vascular bed but also proximally—from the site
of obstruction [1, 22]. This phenomenon could be partly
responsible for increase in the values of central parameters
revealed in patients with recoarctation, as well as an
important link between AP and transaortic gradient.
Observed in our study, lack of correlation between the
residual narrowing of AoD and parameters of peripheral
remodeling conﬁrms the thesis that hypertension in CoAo
patients is not associated with a mechanical obstruction but
rather with the primary stiffness of proximal aortic seg-
ment, resulting from an increase in collagen and a decrease
in smooth muscle cells present in the aortic wall [3, 9, 10,
19, 32]. The reduced elastic properties of the precoarctation
aorta lead to permanent abnormalities in baroreceptor re-
adaptation [3, 9, 10, 21, 29, 39]. Although Vriend et al. [17]
claim that interventional dilatation should be performed
even in case of small residual narrowing of AoD, Chen
et al. [22] have not shown any improvement in the
peripheral arterial remodeling parameters in patients fol-
lowing stent implantation at the site of stenosis, which in
turns seems to support the results obtained in our study.
Undoubtedly, CoAo repair signiﬁcantly improved
prognosis of patients with this congenital heart disease and
long-term observation reveal that prevalence of hyperten-
sion and overall mortality depend on the age at the time of
surgery [5, 13, 14, 22, 33]. However, an increasing number
of researchers support the thesis that even an early opera-
tion may not alter the course of this cardiovascular disease
and will not prevent harmful vascular changes in those
patients [10, 21]. Our analysis revealed no relationship
between age at the operation and arterial reactivity
expressed as FMD and NMD, which conﬁrms earlier
ﬁndings [2, 12, 26]. Heger et al. [27] claim that higher
FMD and NMD were observed in patients operated on
before the age of nine but at the same time they report no
signiﬁcant correlation of those parameters with the age at
the surgery. On the contrary to de Divitiis et al. [12], our
study failed to identify the link between PWV and IMT or
age at the operation. These observations suggest early
determination of vascular changes in CoAo patients, the
mechanism which is likely dependent on potential genetic
or intrauterine factors [21, 40].
Our study showed that parameters related to central
pressure pulse wave—AP, AI and APP—do correlate with
the current age of patients, which is true in general for the
aging population [35], but they do not display any rela-
tionship to the age at the surgery. Increased compliance of
precoarctation aorta after removal of mechanical obstruc-
tion was clearly obtained by Brili et al. [29]. Yet, Vogt
et al. [32] report impaired elastic properties of the
ascending aorta even in newborns after successful CoAo
repair. It seems that even though central parameters are
related to increased general arterial stiffness, pathologic
changes characteristic for ascending aorta in CoAo are
themselves an important independent determinant of vas-
cular remodeling [10, 20]. That validates the claim that
despite early successful repair permanent impairment of
vascular compliance above the place of coarctation might
be the cause of vascular and end-organ complications.
Conclusions
Residual stenosis in the AoD does not affect the arterial
vasodilatation nor stiffness in patients after CoAo repair.
Early operation has no impact on peripheral vascular
remodeling or central pressure which supports the claim
that coarctation of the aorta is a systemic vascular disorder
which leads to progressive vascular and end-organ damage
despite early correction.
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